STERIS Balance Sheet Health
Financial Health criteria checks 3/6
STERIS tiene unos fondos propios totales de $6.2B y una deuda total de $3.4B, lo que sitúa su ratio deuda/fondos propios en 55.5%. Sus activos y pasivos totales son $11.3B y $5.1B respectivamente. STERIS El EBIT de la empresa es de $818.1M, por lo que su ratio de cobertura de intereses es de 6.5. Su tesorería e inversiones a corto plazo ascienden a $213.8M.
Key information
51.5%
Debt to equity ratio
US$3.31b
Debt
| Interest coverage ratio | 6.3x |
| Cash | US$195.59m |
| Equity | US$6.43b |
| Total liabilities | US$5.01b |
| Total assets | US$11.44b |
Recent financial health updates
STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet
Mar 07
We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt
Nov 06These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well
Feb 01STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly
Nov 01Is STERIS (NYSE:STE) A Risky Investment?
Jul 19STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly
Apr 08Recent updates
STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price
Mar 29STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet
Mar 07Steris: Strong Healthcare Products Growth Coupled With Weak AST Business
Feb 17STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't
Feb 15An Intrinsic Calculation For STERIS plc (NYSE:STE) Suggests It's 23% Undervalued
Dec 17Should You Investigate STERIS plc (NYSE:STE) At US$203?
Nov 24Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes
Nov 08We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt
Nov 06Are STERIS plc (NYSE:STE) Investors Paying Above The Intrinsic Value?
Sep 18Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage
Sep 01When Should You Buy STERIS plc (NYSE:STE)?
Aug 10Steris: Continuing To Grow The Product Lineup
Jun 20Steris falls 10% on Q3 revenue, profit miss, 2023 profit guidance lowered
Feb 09Steris declares $0.47 dividend
Feb 01These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well
Feb 01Calculating The Intrinsic Value Of STERIS plc (NYSE:STE)
Dec 28Steris declares $0.47 dividend
Nov 02STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly
Nov 01Steris: Non-GAAP Valuations Supportive Of Substantial Upside
Sep 04STERIS (NYSE:STE) Will Pay A Larger Dividend Than Last Year At $0.47
Aug 18STERIS' (NYSE:STE) Dividend Will Be Increased To $0.47
Aug 04Steris Non-GAAP EPS of $1.90 in-line, revenue of $1.2B misses by $20M
Aug 02Is STERIS (NYSE:STE) A Risky Investment?
Jul 19Steris: Deleveraging Key Undercurrent, Valuation A Concern
Jun 12STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly
Apr 08Steris: Another Essential Healthcare Supply Resource
Feb 01Is STERIS (NYSE:STE) A Risky Investment?
Dec 15STERIS (NYSE:STE) Is Increasing Its Dividend To US$0.43
Nov 01Financial Position Analysis
Pasivos a corto plazo: STELos activos a corto plazo ($2.2B) de la empresa superan a sus pasivos a corto plazo ($873.1M).
Pasivo a largo plazo: Los activos a corto plazo de STE ($2.2B) no cubren sus pasivos a largo plazo ($4.2B).
Debt to Equity History and Analysis
Nivel de deuda: La relación deuda neta-capital de STE (52.1%) se considera alta.
Reducción de la deuda: STEha pasado de 40.6% a 55.5% en los últimos 5 años.
Cobertura de la deuda: STELa deuda de la empresa está bien cubierta por el flujo de caja operativo (24.7%).
Cobertura de intereses: STELos pagos de intereses de su deuda están bien cubiertos por el EBIT (6.5x cobertura).